Renaissance Technologies’s Palisade Bio PALI Stock Holding History
Bought
Maintained
Sold
Other funds holding PALI
BGI
OCA
PA
CC
RCM
EP
Renaissance Technologies's PALI Position: Q1 2026 in Review
Renaissance Technologies reduced its Palisade Bio (PALI) stake by 39% in Q1 2026, selling an estimated $1.69M and leaving 1,454,400 shares worth $2.55M. The position accounts for ﹤0.01% of the portfolio, ranked #1758.
Renaissance Technologies first reported a position in PALI in Q2 2019 and has held it in 15 quarters since. The position peaked at $5.6M in Q4 2025. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.
- Renaissance Technologies held 1,454,400 shares of Palisade Bio worth $2.55M as of Q1 2026.
- Renaissance Technologies sold 928,100 Palisade Bio shares in Q1 2026, an estimated $1.69M.
- Palisade Bio made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #1758 holding.
- Renaissance Technologies first reported a position in Palisade Bio in Q2 2019 and has held it in 15 quarters since.
- Renaissance Technologies's Palisade Bio position peaked at $5.6M in Q4 2025.
- 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.